Surgical resection of soft tissue metastasis in cancers: A single-center study of 77 cases over a 7-year period

Cancer Med. 2023 Dec;12(24):22081-22090. doi: 10.1002/cam4.6808. Epub 2023 Dec 11.

Abstract

Introduction: Soft tissue metastasis (STM) of cancers, encompassing skeletal muscle and subcutaneous tissue metastasis, is less common due to unique homeostatic conditions. With longer life expectancy and the advent of new imaging modalities, clinical physicians will increasingly encounter and manage such cases. This study retrospectively reviewed cases of STM in visceral cancers who underwent surgery at Fudan University Shanghai Cancer Center over a 7-year period.

Methods: Data were collected through a comprehensive review of medical records, including demographic variables, primary tumor characteristics, surgical data, tumor pathology, and outcomes. Survival analysis was performed using Kaplan-Meier curves.

Results: The study included 77 cases with a median follow-up period of 854 days. The most common primary tumor sites were the lung (11) and breast (10). The abdominal wall was the most frequent site of metastasis. The combination of visceral metastasis, age over 52 years, and a history of primary tumor correlates with a poorer prognosis. Surgical-related metastases are associated with a higher degree of differentiation. Additionally, we have identified a better prognosis for patients with cancer of unknown primary (CUP) exhibiting potential resectable soft tissue metastases.

Conclusion: The combination of visceral metastasis, age over 52 years, and a history of primary tumor suggest a poorer prognosis. While no significant impact on survival was observed for patients with lymph node metastasis. Surgical-related metastases are associated with a higher degree of differentiation. CUP patients with potentially resectable soft tissue metastases should be considered for surgical intervention.

Keywords: cancer of unknown primary; port site metastasis; soft tissue metastasis; survival analysis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • China / epidemiology
  • Humans
  • Middle Aged
  • Neoplasms, Second Primary*
  • Prognosis
  • Retrospective Studies
  • Sarcoma* / pathology
  • Soft Tissue Neoplasms* / surgery